Biosphere tenant Iksuda Therapeutics presents first data on lead antibody drug conjugate, demonstrating effective tumour regression.

By |2022-02-18T10:20:26+00:00September 30th, 2019|Archive|

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), today announced… Continue Reading Biosphere tenant Iksuda Therapeutics presents first data on lead antibody drug conjugate, demonstrating effective tumour regression.

Read Article
Comments Off on Biosphere tenant Iksuda Therapeutics presents first data on lead antibody drug conjugate, demonstrating effective tumour regression.

Transformational cell technology helping to improve lives across the world

By |2022-02-18T10:20:12+00:00September 5th, 2019|Archive|

Atelerix is a spin out from Newcastle University and pioneers in the storage and… Continue Reading Transformational cell technology helping to improve lives across the world

Read Article
Comments Off on Transformational cell technology helping to improve lives across the world

The Biosphere has been shortlisted for ‘Best Sector Support’ award in the OBN Awards 2019

By |2022-02-18T10:19:56+00:00September 5th, 2019|Archive|

The Biosphere has been recognised for outstanding levels of support to companies in the… Continue Reading The Biosphere has been shortlisted for ‘Best Sector Support’ award in the OBN Awards 2019

Read Article
Comments Off on The Biosphere has been shortlisted for ‘Best Sector Support’ award in the OBN Awards 2019

EU Logo
Northern Powerhouse Logo
NE LEP
Newcastle Council Logo
Newcastle Helix Logo

The Biosphere is part of the Newcastle Helix community.

It is part funded by the England European
Regional Development fund as part of the European Structural And Investment Funds Growth Programme 2014-2020 and the North East Local Growth Fund from HM Government, Administered by the North East Local Enterprise Partnership.

Get in touch
Request a callback
Skip to content
This Website is committed to ensuring digital accessibility for people with disabilitiesWe are continually improving the user experience for everyone, and applying the relevant accessibility standards.
Conformance status
Developed by AGHAI Web Development
Go to Top